American Society of Addiction Medicine
The Voice of Addiction Medicine
Support ASAM's mission and build a future generation of addiction medicine specialists.
Newly released and available for purchase. Order now with your special ASAM member discount.
ASAM is uniting the field by creating an interdisciplinary community to share research, treatments and experience.
Explore exciting new opportunities to learn how to enhance your practice and improve patient outcomes.
Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry...
The American Society of Addiction Medicine (ASAM) applauds the Secretaries of the Departments of Labor, Health and Human Services and Treasury for releasing final regulations that implement the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA).
The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the rescheduling of hydrocodone combination products since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.” ASAM has since sent additional letters to the FDA, has testified before the FDA Drug Safety and Risk Management Advisory Committee and has supported U.S. House and Senate legislative language, all calling for the rescheduling of hydrocodone.
On October 23rd, ASAM hosted Legislative Day at Capitol Hill. Legislative Day is an opportunity for ASAM members to meet with their Congressional leaders to discuss key ASAM issues, share concerns and impart their expertise on issues related to drug and addiction treatment policies. The day began with an advocacy training and breakfast orientation in Washington, D.C. Congressman Tim Ryan (Ohio) spoke at the morning’s event, provided tips and answered members’ questions.
The leading source for ASAM society and addiction medicine news, engaging ASAM leaders, membership and the public in the work of advancing ASAM’s core purpose and mission.
Published six times per year, the Journal of Addiction Medicine is the official journal of ASAM. It is designed for all physicians and other mental health professionals who need to keep up-to-date with the treatment of addiction disorders.
Risk Evaluation and Mitigation Strategies (REMS) training for prescribers of Extended Release/Long Acting (ER/LA) Opioids provided in a 3 hour course.
Online SBIRT Training, in partnership with Clinical Tools, Inc.
Our nationwide directory of addiction medicine professionals.
Most teenagers who abuse prescription drugs are given them for free by a friend or relative.
© 2013 American Society of Addiction Medicine. All rights reserved.
4601 N. Park Avenue, Upper Arcade #101, Chevy Chase, MD 20815
Phone: 301-656-3920 |
Fax: 301-656-3815 |
Association Web Design by Matrix Group International, Inc.
Connect With Us